Location History:
- Bentleigh, AU (2011 - 2014)
- Melbourne, AU (2013 - 2016)
Company Filing History:
Years Active: 2011-2016
Title: Marcel Robert Kling: Innovator in N-Containing Heterocyclic Compounds
Introduction
Marcel Robert Kling is a notable inventor based in Bentleigh, Australia. He has made significant contributions to the field of medicinal chemistry, particularly in the development of N-containing heterocyclic compounds. With a total of 5 patents to his name, Kling's work focuses on creating innovative solutions for various diseases.
Latest Patents
Kling's latest patents revolve around N-containing heterocyclic compounds that serve as inhibitors of protein kinases, including JAK kinases. These compounds are specifically selective for JAK1, JAK2, JAK3, or TYK2 kinases, and combinations such as JAK1 and JAK2. The kinase inhibitors developed by Kling can be utilized in the treatment of several kinase-associated diseases, including immunological and inflammatory diseases, hyperproliferative diseases like cancer, viral diseases, metabolic diseases, and vascular diseases.
Career Highlights
Marcel Robert Kling is currently associated with Ym Biosciences Australia Pty Ltd., where he continues to advance his research and development efforts. His work has been instrumental in the field of drug discovery, particularly in targeting specific kinases that play a crucial role in various diseases.
Collaborations
Kling has collaborated with notable colleagues, including Christopher John Burns and David Gerard Bourke. These collaborations have further enhanced the research and development of innovative therapeutic solutions.
Conclusion
Marcel Robert Kling is a distinguished inventor whose work in N-containing heterocyclic compounds has the potential to impact the treatment of numerous diseases. His contributions to medicinal chemistry and ongoing research efforts continue to pave the way for advancements in healthcare.